Marc Wolff

Marc Wolff is a seasoned executive with extensive experience in the biotechnology sector, currently serving as a Member of the Board of Directors at Oncodea and Chief Executive Officer at Hive & Colony Management. Additional roles include Partner at Kineticos Disruptor Fund, which focuses on disruptive technologies in healthcare, and board member positions at JURA Bio, Inc. and Lacerta Therapeutics, dedicated to addressing rare genetic disorders. Wolff previously held leadership roles as Chief Executive Officer at Calviri, aiming to revolutionize cancer treatment, and Chief Operating Officer at Aldevron, where strategic operations were managed across multiple global facilities. Other noteworthy positions include Chief Financial Officer roles at Intelligent Quisine and JHP Pharmaceuticals, where a significant acquisition was completed. Marc Wolff holds a Master in Management with a specialization in International Finance from NEOMA Business School.